BTZ and CFZ inhibited cell growth in a dose-dependent manner in all MM cell lines, The MM cell lines exhibited far more sensitivity to the proteasome inhibitors BTZ and CFZ than did the BMSC lines (Fig 1A). The gene discussed is CASC3; the disease is Miyoshi myopathy.